<!DOCTYPE html>
<html lang="en" dir="auto">

<head>
<head>
    <title>immunology</title>
    <meta charset="utf-8">
    <meta name="description"
        content="Website meta description for google search results go here" />
    <meta name="dc.relation" content="https://trxiv.yorks0n.com" />
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <meta name="theme-color" content="#1A94D2" />

    

    
    
    
    <link rel="stylesheet" href="/css/main.min.css" media="screen">

</head>


<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="robots" content="index, follow">
<title>immunology | TRxiv2</title>
<meta name="keywords" content="">
<meta name="description" content="Sensitivity of BA.2.86 to prevailing neutralising antibody responses
Authors: Sheward, D. J.; Yang, Y.; Westerberg, M.; Öling, S.; Muschiol, S.; Sato, K.; Peacock, T. P.; Karlsson Hedestam, G. B.; Albert, J.; Murrell, B.
Score: 374.0, Published: 2023-09-04 DOI: 10.1101/2023.09.02.556033
A new SARS-CoV-2 variant, designated BA.2.86, has recently emerged with over 30 spike mutations relative to its parental BA.2, raising questions about its degree of resistance to neutralising antibodies. Using a spike-pseudotyped virus model we characterise neutralisation of BA.">
<meta name="author" content="">
<link rel="canonical" href="https://trxiv.yorks0n.com/posts/immunology/">
<link crossorigin="anonymous" href="/assets/css/stylesheet.904bd1e751cdd2a584fa6bed3fa1166dfd8ec9949ebfd0c4d69c5add5e17c23d.css" integrity="sha256-kEvR51HN0qWE&#43;mvtP6EWbf2OyZSev9DE1pxa3V4Xwj0=" rel="preload stylesheet" as="style">
<script defer crossorigin="anonymous" src="/assets/js/highlight.f413e19d0714851f6474e7ee9632408e58ac146fbdbe62747134bea2fa3415e0.js" integrity="sha256-9BPhnQcUhR9kdOfuljJAjlisFG&#43;9vmJ0cTS&#43;ovo0FeA="
    onload="hljs.initHighlightingOnLoad();"></script>
<link rel="icon" href="https://trxiv.yorks0n.com/favicon.ico">
<link rel="icon" type="image/png" sizes="16x16" href="https://trxiv.yorks0n.com/favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://trxiv.yorks0n.com/favicon-32x32.png">
<link rel="apple-touch-icon" href="https://trxiv.yorks0n.com/apple-touch-icon.png">
<link rel="mask-icon" href="https://trxiv.yorks0n.com/safari-pinned-tab.svg">
<meta name="theme-color" content="#2e2e33">
<meta name="msapplication-TileColor" content="#2e2e33">
<noscript>
    <style>
        #theme-toggle,
        .top-link {
            display: none;
        }

    </style>
    <style>
        @media (prefers-color-scheme: dark) {
            :root {
                --theme: rgb(29, 30, 32);
                --entry: rgb(46, 46, 51);
                --primary: rgb(218, 218, 219);
                --secondary: rgb(155, 156, 157);
                --tertiary: rgb(65, 66, 68);
                --content: rgb(196, 196, 197);
                --hljs-bg: rgb(46, 46, 51);
                --code-bg: rgb(55, 56, 62);
                --border: rgb(51, 51, 51);
            }

            .list {
                background: var(--theme);
            }

            .list:not(.dark)::-webkit-scrollbar-track {
                background: 0 0;
            }

            .list:not(.dark)::-webkit-scrollbar-thumb {
                border-color: var(--theme);
            }
        }

    </style>
</noscript><meta property="og:title" content="immunology" />
<meta property="og:description" content="Sensitivity of BA.2.86 to prevailing neutralising antibody responses
Authors: Sheward, D. J.; Yang, Y.; Westerberg, M.; Öling, S.; Muschiol, S.; Sato, K.; Peacock, T. P.; Karlsson Hedestam, G. B.; Albert, J.; Murrell, B.
Score: 374.0, Published: 2023-09-04 DOI: 10.1101/2023.09.02.556033
A new SARS-CoV-2 variant, designated BA.2.86, has recently emerged with over 30 spike mutations relative to its parental BA.2, raising questions about its degree of resistance to neutralising antibodies. Using a spike-pseudotyped virus model we characterise neutralisation of BA." />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://trxiv.yorks0n.com/posts/immunology/" /><meta property="article:section" content="posts" />
<meta property="article:published_time" content="2023-09-06T10:39:07+00:00" />
<meta property="article:modified_time" content="2023-09-06T10:39:07+00:00" />

<meta name="twitter:card" content="summary"/>
<meta name="twitter:title" content="immunology"/>
<meta name="twitter:description" content="Sensitivity of BA.2.86 to prevailing neutralising antibody responses
Authors: Sheward, D. J.; Yang, Y.; Westerberg, M.; Öling, S.; Muschiol, S.; Sato, K.; Peacock, T. P.; Karlsson Hedestam, G. B.; Albert, J.; Murrell, B.
Score: 374.0, Published: 2023-09-04 DOI: 10.1101/2023.09.02.556033
A new SARS-CoV-2 variant, designated BA.2.86, has recently emerged with over 30 spike mutations relative to its parental BA.2, raising questions about its degree of resistance to neutralising antibodies. Using a spike-pseudotyped virus model we characterise neutralisation of BA."/>


<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BreadcrumbList",
  "itemListElement": [, 
    {
      "@type": "ListItem",
      "position":  2 ,
      "name": "Posts",
      "item": "https://trxiv.yorks0n.com/posts/"
    }, 
    {
      "@type": "ListItem",
      "position":  3 ,
      "name": "immunology",
      "item": "https://trxiv.yorks0n.com/posts/immunology/"
    }
  ]
}
</script>
<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BlogPosting",
  "headline": "immunology",
  "name": "immunology",
  "description": "Sensitivity of BA.2.86 to prevailing neutralising antibody responses\nAuthors: Sheward, D. J.; Yang, Y.; Westerberg, M.; Öling, S.; Muschiol, S.; Sato, K.; Peacock, T. P.; Karlsson Hedestam, G. B.; Albert, J.; Murrell, B.\nScore: 374.0, Published: 2023-09-04 DOI: 10.1101/2023.09.02.556033\nA new SARS-CoV-2 variant, designated BA.2.86, has recently emerged with over 30 spike mutations relative to its parental BA.2, raising questions about its degree of resistance to neutralising antibodies. Using a spike-pseudotyped virus model we characterise neutralisation of BA.",
  "keywords": [
    
  ],
  "articleBody": " Sensitivity of BA.2.86 to prevailing neutralising antibody responses\nAuthors: Sheward, D. J.; Yang, Y.; Westerberg, M.; Öling, S.; Muschiol, S.; Sato, K.; Peacock, T. P.; Karlsson Hedestam, G. B.; Albert, J.; Murrell, B.\nScore: 374.0, Published: 2023-09-04 DOI: 10.1101/2023.09.02.556033\nA new SARS-CoV-2 variant, designated BA.2.86, has recently emerged with over 30 spike mutations relative to its parental BA.2, raising questions about its degree of resistance to neutralising antibodies. Using a spike-pseudotyped virus model we characterise neutralisation of BA.2.86 by clinically relevant monoclonal antibodies and by two cohorts of serum sampled from Stockholm, including both a recent cohort, and one sampled prior to the arrival of XBB in Sweden.\nXBB.1.5 Spike Protein COVID-19 Vaccine Induces Broadly Neutralizing and Cellular Immune Responses Against EG.5.1 and Emerging XBB Variants\nAuthors: Patel, N.; Trost, J. F.; Guebre-Xabier, M.; Zhou, H.; Norton, J.; Jiang, D.; Cai, Z.; Zhu, M.; Marchese, A. M.; Greene, A. M.; Mallory, R. M.; Kalkeri, R.; Dubovsky, F.; Smith, G.\nScore: 239.4, Published: 2023-08-31 DOI: 10.1101/2023.08.30.554497\nMonovalent SARS-CoV-2 Prototype (Wuhan-Hu-1) and bivalent (Prototype + BA.4/5) COVID-19 vaccines have demonstrated a waning of vaccine-mediated immunity highlighted by lower neutralizing antibody responses against SARS-CoV-2 Omicron XBB sub-variants. The reduction of humoral immunity due to the rapid evolution of SARS-CoV-2 has signaled the need for an update to vaccine composition. A strain change for all authorized/approved vaccines to a monovalent composition with Omicron subvariant XBB.1.5 has been supported by the WHO, EMA, and FDA. Here, we demonstrate that immunization with a monovalent recombinant spike protein COVID-19 vaccine (Novavax, Inc.) based on the subvariant XBB.1.5 induces cross-neutralizing antibodies against XBB.1.5, XBB.1.16, XBB.2.3, EG.5.1, and XBB.1.16.6 subvariants, promotes higher pseudovirus neutralizing antibody titers than bivalent (Prototype + XBB.1.5) vaccine, induces SARS-CoV-2 spike-specific Th1-biased CD4+ T-cell responses against XBB subvariants, and robustly boosts antibody responses in mice and nonhuman primates primed with a variety of monovalent and bivalent vaccines. Together, these data support updating the Novavax vaccine to a monovalent XBB.1.5 formulation for the 2023-2024 COVID-19 vaccination campaign.\nSARS-CoV-2 infection triggers pro-atherogenic inflammatory 1 responses in human coronary vessels\nAuthors: Eberhardt, N.; Noval, M. G.; Kaur, R.; Sajja, S.; Amadori, L.; Das, D.; Cilhoroz, B.; Stewart, O. J.; Fernandez, D. M.; Shamailova, R.; Guillen, A. V.; Jangra, S.; Schotsaert, M.; Gildea, M.; Newman, J. D.; Faries, P.; Maldonado, T.; Rockman, C.; Rapkiewicz, A.; Stapleford, K. A.; Narula, N.; Moore, K. J.; Giannarelli, C.\nScore: 368.9, Published: 2023-08-15 DOI: 10.1101/2023.08.14.553245\nCOVID-19 patients present higher risk for myocardial infarction (MI), acute coronary syndrome, and stroke for up to 1 year after SARS-CoV-2 infection. While the systemic inflammatory response to SARS-CoV-2 infection likely contributes to this increased cardiovascular risk, whether SARS-CoV-2 directly infects the coronary vasculature and attendant atherosclerotic plaques to locally promote inflammation remains unknown. Here, we report that SARS-CoV-2 viral RNA (vRNA) is detectable and replicates in coronary atherosclerotic lesions taken at autopsy from patients with severe COVID-19. SARS-CoV-2 localizes to plaque macrophages and shows a stronger tropism for arterial lesions compared to corresponding perivascular fat, correlating with the degree of macrophage infiltration. In vitro infection of human primary macrophages highlights that SARS-CoV-2 entry is increased in cholesterol-loaded macrophages (foam cells) and is dependent, in part, on neuropilin-1 (NRP-1). Furthermore, although viral replication is abortive, SARS-CoV-2 induces a robust inflammatory response that includes interleukins IL-6 and IL-1{beta}, key cytokines known to trigger ischemic cardiovascular events. SARS-CoV-2 infection of human atherosclerotic vascular explants recapitulates the immune response seen in cultured macrophages, including pro-atherogenic cytokine secretion. Collectively, our data establish that SARS-CoV-2 infects macrophages in coronary atherosclerotic lesions, resulting in plaque inflammation that may promote acute CV complications and long-term risk for CV events.\nImmune Evasion and Membrane Fusion of SARS-CoV-2 XBB Subvariants EG.5.1 and XBB.2.3\nAuthors: Faraone, J. N.; Qu, P.; Goodarzi, N.; Zheng, Y.-M.; Carlin, C.; Saif, L. J.; Oltz, E. M.; Xu, K.; Jones, D.; Gumina, R. J.; Liu, S.-L.\nScore: 76.4, Published: 2023-08-30 DOI: 10.1101/2023.08.30.555188\nImmune evasion by SARS-CoV-2 paired with immune imprinting from monovalent mRNA vaccines has resulted in attenuated neutralizing antibody responses against Omicron subvariants. In this study, we characterized two new XBB variants rising in circulation -- EG.5.1 and XBB.2.3, for their ability of neutralization and syncytia formation. We determined the neutralizing antibody in sera of individuals that received a bivalent mRNA vaccine booster, BA.4/5-wave infection, or XBB.1.5-wave infection. Bivalent vaccination-induced antibodies neutralized efficiently ancestral D614G, but to a much less extent, two new EG.5.1 and XBB.2.3 variants. In fact, the enhanced neutralization escape of EG.5.1 appeared to be driven by its key defining mutation XBB.1.5-F456L. Notably, infection by BA.4/5 or XBB.1.5 afforded little, if any, neutralization against EG.5.1, XBB.2.3 and previous XBB variants -- especially in unvaccinated individuals, with average neutralizing antibody titers near the limit of detection. Additionally, we investigated the infectivity, fusion activity, and processing of variant spikes for EG.5.1 and XBB.2.3 in HEK293T-ACE2 and CaLu-3 cells but found no significant differences compared to earlier XBB variants. Overall, our findings highlight the continued immune evasion of new Omicron subvariants and, more importantly, the need to reformulate mRNA vaccines to include XBB spikes for better protection.\nConvergent evolution of SARS-CoV-2 XBB lineages on receptor-binding domain 455-456 enhances antibody evasion and ACE2 binding\nAuthors: Jian, F.; Yang, S.; Yu, Y.; Song, W.; Yisimayi, A.; Chen, X.; Xu, Y.; Wang, P.; Yu, L.; Wang, J.; Liu, L.; Niu, X.; Wang, J.; Xiao, T.; Gu, Q.; Shao, F.; Jin, R.; Shen, Z.; Wang, Y.; Cao, Y. R.\nScore: 53.9, Published: 2023-08-31 DOI: 10.1101/2023.08.30.555211\nSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) XBB lineages have achieved dominance worldwide and keep on evolving. Convergent evolution of XBB lineages on the receptor-binding domain (RBD) L455F and F456L is observed, resulting in variants like EG.5, FL.1.5.1, XBB.1.5.70, and HK.3. Here, we show that neutralizing antibody (NAb) evasion drives the convergent evolution of F456L, while the epistatic shift caused by F456L enables the subsequent convergence of L455F through ACE2 binding enhancement and further immune evasion. Specifically, L455F and F456L evades Class 1 NAbs, which could reduce the neutralization efficacy of XBB breakthrough infection (BTI) and reinfection convalescent plasma. Importantly, L455F single substitution significantly dampens receptor binding; however, the combination of L455F and F456L forms an adjacent residue flipping, which leads to enhanced NAbs resistance and ACE2 binding affinity. Our results indicate the evolution flexibility contributed by epistasis cannot be underestimated, and the evolution potential of SARS-CoV-2 RBD remains high. HighlightsO_LIL455F and F456L enhance the resistance to Class 1 NAbs C_LIO_LIL455F and F456L lower neutralization of XBB BTI convalescent plasma C_LIO_LIL455F+F456L flipping significantly increases ACE2 binding affinity C_LI\nAltered DNA methylation underlies monocyte dysregulation and innate exhaustion memory in sepsis\nAuthors: Caldwell, B. A.; Wu, Y.; Wang, J.; Li, L.\nScore: 48.6, Published: 2023-08-31 DOI: 10.1101/2023.08.30.555580\nInnate immune memory is the process by which pathogen exposure elicits cell-intrinsic states to alter the strength of future immune challenges. Such altered memory states drive monocyte dysregulation during sepsis, promoting pathogenic behavior characterized by pro-inflammatory, immunosuppressive gene expression in concert with emergency hematopoiesis. Epigenetic changes, notably in the form of histone modifications, have been shown to underlie innate immune memory, but the contribution of DNA methylation to this process remains poorly understood. Using an ex vivo sepsis model, we discovered broad changes in DNA methylation throughout the genome of exhausted monocytes, including at several genes previously implicated as major drivers of immune dysregulation during sepsis and Covid-19 infection (e.g. Plac8). Methylome alterations are driven in part by Wnt signaling inhibition in exhausted monocytes, and can be reversed through treatment with DNA methyltransferase inhibitors, Wnt agonists, or immune training molecules. Importantly, these changes are recapitulated in septic mice following cecal slurry injection, resulting in stable changes at critical immune genes that support the involvement of DNA methylation in acute and long-term monocyte dysregulation during sepsis.\nAntigenicity and infectivity characterization of SARS-CoV-2 BA.2.86\nAuthors: Yang, S.; Yu, Y.; Jian, F.; Song, W.; Yisimayi, A.; Chen, X.; Xu, Y.; Wang, P.; Yu, L.; Wang, J.; Niu, X.; Wang, J.; Xiao, T.; An, R.; Wang, Y.; Gu, Q.; Shao, F.; Jin, R.; Shen, Z.; Wang, Y.; Cao, Y. R.\nScore: 33.8, Published: 2023-09-04 DOI: 10.1101/2023.09.01.555815\nThe recently identified SARS-CoV-2 variant, BA.2.86, which carries a substantial number of Spike mutations, has raised a global alarm. An immediate assessment of its antigenic properties and infectivity is necessary. Here, we reveal the distinct antigenicity of BA.2.86 compared with previous variants including XBB.1.5. BA.2.86 significantly evades convalescent plasma from XBB breakthrough infection (BTI) and reinfections. Key mutations that mediate the enhanced resistance include N450D, K356T, L452W, A484K, V483del, and V445H on the RBD, while BA.2.86's NTD mutations and E554K on SD1 also largely contribute. However, we found that BA.2.86 pseudovirus exhibits compromised efficiency of infecting HEK293T-hACE2 cells compared to XBB.1.5 and EG.5, which may be caused by K356T, V483del, and E554K, and could potentially limit BA.2.86's transmissibility. In sum, it appears that BA.2.86 has traded its infectivity for higher immune evasion during long-term host-viral evolution. Close attention should be paid to monitoring additional mutations that could improve BA.2.86's infectivity.\nTick hemocytes have pleiotropic roles in microbial infection and arthropod fitness\nAuthors: Rolandelli, A.; Laukaitis-Yousey, H.; Bogale, H.; Singh, N.; Samaddar, S.; ONeal, A.; Ferraz, C.; Butnaru, M.; Mameli, E.; Xia, B.; Mendes, M. T.; Butler, L. R.; Marnin, L.; Cabrera Paz, F.; Valencia, L.; Rana, V.; Skerry, C.; Pal, U.; Mohr, S.; Perrimon, N.; Serre, D.; Pedra, J.\nScore: 15.9, Published: 2023-09-03 DOI: 10.1101/2023.08.31.555785\nUncovering the complexity of systems in non-model organisms is critical for understanding arthropod immunology. Prior efforts have mostly focused on Dipteran insects, which only account for a subset of existing arthropod species in nature. Here, we describe immune cells or hemocytes from the clinically relevant tick Ixodes scapularis using bulk and single cell RNA sequencing combined with depletion via clodronate liposomes, RNA interference, Clustered Regularly Interspaced Short Palindromic Repeats activation (CRISPRa) and RNA-fluorescence in situ hybridization (FISH). We observe molecular alterations in hemocytes upon tick infestation of mammals and infection with either the Lyme disease spirochete Borrelia burgdorferi or the rickettsial agent Anaplasma phagocytophilum. We predict distinct hemocyte lineages and reveal clusters exhibiting defined signatures for immunity, metabolism, and proliferation during hematophagy. Furthermore, we perform a mechanistic characterization of two I. scapularis hemocyte markers: hemocytin and astakine. Depletion of phagocytic hemocytes affects hemocytin and astakine levels, which impacts blood feeding and molting behavior of ticks. Hemocytin specifically affects the c-Jun N-terminal kinase (JNK) signaling pathway, whereas astakine alters hemocyte proliferation in I. scapularis. Altogether, we uncover the heterogeneity and pleiotropic roles of hemocytes in ticks and provide a valuable resource for comparative biology in arthropods.\nUnanticipated interacting features of human gut-associated lymphoid tissues link microbiota, intestinal immunity and autoimmunity\nAuthors: Montorsi, L.; Pitcher, M. J.; Zhao, Y.; Demonti, A.; Tull, T. J.; Dionisi, C.; Dhami, P.; Ellis, R. J.; Bishop, C.; Sanderson, J.; Jain, S.; D'Cruz, D.; Gibbons, D.; Winkler, T. H.; Bemark, M.; Ciccarelli, F. D.; Spencer, J.\nScore: 14.7, Published: 2023-08-31 DOI: 10.1101/2023.08.29.555265\nGut-associated lymphoid tissue (GALT) is organised lymphoid tissue that is chronically activated by the intestinal microbiota. It generates the IgA response that is critical for intestinal homeostasis. By iterative application of multiplexed technologies, we identify enrichment of double-negative 2 (DN2:CD27-IgD-CD21loCD11chi) B cells in GALT, where they comprise the majority of intraepithelial and subepithelial B cells. We show that DN2 B cells in GALT interact with DC in the sub-epithelial dome that express DNASE1L3 and microbicides. Unlike in mice, DNASE1L3 in humans does not associate with apoptotic debris, but is located between sampled bacteria and host tissue where it is co-expressed with C1Q, consistent with management of bacterial debris. Thus we demonstrate that DN2 B cells that are otherwise associated with lupus nephritis, and DNASE1L3 and C1q that are lupus autoantigens, are microbiota-associated, interacting components of normal intestinal immunity.\nDysregulation of γδ intraepithelial lymphocytes precedes Crohn's disease-like ileitis\nAuthors: Xu, W.; Golovchenko, N. B.; Fong, A.; Achi, S.; Bucar, E. B.; Vidmar, K. J.; Zhang, L.; Frey, M. R.; Prinz, I.; Pizarro, T. T.; Kollias, G.; Edelblum, K. L.\nScore: 14.4, Published: 2023-09-03 DOI: 10.1101/2023.08.31.555710\nIntraepithelial lymphocytes expressing the {gamma}{delta} T cell receptor ({gamma}{delta} IELs) provide immunosurveillance of the intestinal barrier. Interestingly, {gamma}{delta} IEL number is reduced in patients with active Crohn's disease (CD). Here, we report an underappreciated role for {gamma}{delta} IELs in maintaining mucosal tolerance during the onset and progression of CD-like ileitis using the TNF{Delta}ARE/+ mouse model. Decreased epithelial HNF4G/BTNL expression is followed by a loss of ileal {gamma}{delta} IELs and impaired barrier surveillance prior to the histological onset of disease. A reduction of immunoregulatory CD39+ {gamma}{delta} IELs coincides with the influx of immature, peripheral CD39- {gamma}{delta} T cells into the epithelium leading to an expansion of induced IELs, while an earlier depletion of {gamma}{delta} IELs correlates with accelerated onset of ileal inflammation. Our findings identify multiple layers of {gamma}{delta} IEL dysregulation prior to ileitis development indicating that the loss of tissue-resident immunoregulatory {gamma}{delta} IELs may contribute to the initiation of ileal CD.\n",
  "wordCount" : "2152",
  "inLanguage": "en",
  "datePublished": "2023-09-06T10:39:07Z",
  "dateModified": "2023-09-06T10:39:07Z",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://trxiv.yorks0n.com/posts/immunology/"
  },
  "publisher": {
    "@type": "Organization",
    "name": "TRxiv2",
    "logo": {
      "@type": "ImageObject",
      "url": "https://trxiv.yorks0n.com/favicon.ico"
    }
  }
}
</script>
</head>

<body class="" id="top">
<script>
    if (localStorage.getItem("pref-theme") === "dark") {
        document.body.classList.add('dark');
    } else if (localStorage.getItem("pref-theme") === "light") {
        document.body.classList.remove('dark')
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
        document.body.classList.add('dark');
    }

</script>

<header class="header">
    <nav class="nav">
        <div class="logo">
            <a href="https://trxiv.yorks0n.com" accesskey="h" title="TRxiv2 (Alt + H)">TRxiv2</a>
            <div class="logo-switches">
                <button id="theme-toggle" accesskey="t" title="(Alt + T)">
                    <svg id="moon" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <path d="M21 12.79A9 9 0 1 1 11.21 3 7 7 0 0 0 21 12.79z"></path>
                    </svg>
                    <svg id="sun" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <circle cx="12" cy="12" r="5"></circle>
                        <line x1="12" y1="1" x2="12" y2="3"></line>
                        <line x1="12" y1="21" x2="12" y2="23"></line>
                        <line x1="4.22" y1="4.22" x2="5.64" y2="5.64"></line>
                        <line x1="18.36" y1="18.36" x2="19.78" y2="19.78"></line>
                        <line x1="1" y1="12" x2="3" y2="12"></line>
                        <line x1="21" y1="12" x2="23" y2="12"></line>
                        <line x1="4.22" y1="19.78" x2="5.64" y2="18.36"></line>
                        <line x1="18.36" y1="5.64" x2="19.78" y2="4.22"></line>
                    </svg>
                </button>
            </div>
        </div>
        <ul id="menu">
        </ul>
    </nav>
</header>
<main class="main">
<article class="post-single">
  <header class="post-header">
    
    <h1 class="post-title">
      immunology
    </h1>
    <div class="post-meta"><span>updated on September 6, 2023</span>

</div>
  </header> 
  <div class="post-content"><div class="accordion accordion-flush" id="accordionFlushExample"><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.09.02.556033">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.09.02.556033" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.09.02.556033">
        <p class="paperTitle">Sensitivity of BA.2.86 to prevailing neutralising antibody responses</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.09.02.556033" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.09.02.556033" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Sheward, D. J.; Yang, Y.; Westerberg, M.; Öling, S.; Muschiol, S.; Sato, K.; Peacock, T. P.; Karlsson Hedestam, G. B.; Albert, J.; Murrell, B.</p>
        <p class="info">Score: 374.0, Published: 2023-09-04 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.09.02.556033' target='https://doi.org/10.1101/2023.09.02.556033'> 10.1101/2023.09.02.556033</a></p>
        <p class="abstract">A new SARS-CoV-2 variant, designated BA.2.86, has recently emerged with over 30 spike mutations relative to its parental BA.2, raising questions about its degree of resistance to neutralising antibodies. Using a spike-pseudotyped virus model we characterise neutralisation of BA.2.86 by clinically relevant monoclonal antibodies and by two cohorts of serum sampled from Stockholm, including both a recent cohort, and one sampled prior to the arrival of XBB in Sweden.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.08.30.554497">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.08.30.554497" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.08.30.554497">
        <p class="paperTitle">XBB.1.5 Spike Protein COVID-19 Vaccine Induces Broadly Neutralizing and Cellular Immune Responses Against EG.5.1 and Emerging XBB Variants</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.08.30.554497" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.08.30.554497" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Patel, N.; Trost, J. F.; Guebre-Xabier, M.; Zhou, H.; Norton, J.; Jiang, D.; Cai, Z.; Zhu, M.; Marchese, A. M.; Greene, A. M.; Mallory, R. M.; Kalkeri, R.; Dubovsky, F.; Smith, G.</p>
        <p class="info">Score: 239.4, Published: 2023-08-31 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.08.30.554497' target='https://doi.org/10.1101/2023.08.30.554497'> 10.1101/2023.08.30.554497</a></p>
        <p class="abstract">Monovalent SARS-CoV-2 Prototype (Wuhan-Hu-1) and bivalent (Prototype &#43; BA.4/5) COVID-19 vaccines have demonstrated a waning of vaccine-mediated immunity highlighted by lower neutralizing antibody responses against SARS-CoV-2 Omicron XBB sub-variants. The reduction of humoral immunity due to the rapid evolution of SARS-CoV-2 has signaled the need for an update to vaccine composition. A strain change for all authorized/approved vaccines to a monovalent composition with Omicron subvariant XBB.1.5 has been supported by the WHO, EMA, and FDA. Here, we demonstrate that immunization with a monovalent recombinant spike protein COVID-19 vaccine (Novavax, Inc.) based on the subvariant XBB.1.5 induces cross-neutralizing antibodies against XBB.1.5, XBB.1.16, XBB.2.3, EG.5.1, and XBB.1.16.6 subvariants, promotes higher pseudovirus neutralizing antibody titers than bivalent (Prototype &#43; XBB.1.5) vaccine, induces SARS-CoV-2 spike-specific Th1-biased CD4&#43; T-cell responses against XBB subvariants, and robustly boosts antibody responses in mice and nonhuman primates primed with a variety of monovalent and bivalent vaccines. Together, these data support updating the Novavax vaccine to a monovalent XBB.1.5 formulation for the 2023-2024 COVID-19 vaccination campaign.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.08.14.553245">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.08.14.553245" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.08.14.553245">
        <p class="paperTitle">SARS-CoV-2 infection triggers pro-atherogenic inflammatory 1 responses in human coronary vessels</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.08.14.553245" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.08.14.553245" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Eberhardt, N.; Noval, M. G.; Kaur, R.; Sajja, S.; Amadori, L.; Das, D.; Cilhoroz, B.; Stewart, O. J.; Fernandez, D. M.; Shamailova, R.; Guillen, A. V.; Jangra, S.; Schotsaert, M.; Gildea, M.; Newman, J. D.; Faries, P.; Maldonado, T.; Rockman, C.; Rapkiewicz, A.; Stapleford, K. A.; Narula, N.; Moore, K. J.; Giannarelli, C.</p>
        <p class="info">Score: 368.9, Published: 2023-08-15 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.08.14.553245' target='https://doi.org/10.1101/2023.08.14.553245'> 10.1101/2023.08.14.553245</a></p>
        <p class="abstract">COVID-19 patients present higher risk for myocardial infarction (MI), acute coronary syndrome, and stroke for up to 1 year after SARS-CoV-2 infection. While the systemic inflammatory response to SARS-CoV-2 infection likely contributes to this increased cardiovascular risk, whether SARS-CoV-2 directly infects the coronary vasculature and attendant atherosclerotic plaques to locally promote inflammation remains unknown. Here, we report that SARS-CoV-2 viral RNA (vRNA) is detectable and replicates in coronary atherosclerotic lesions taken at autopsy from patients with severe COVID-19. SARS-CoV-2 localizes to plaque macrophages and shows a stronger tropism for arterial lesions compared to corresponding perivascular fat, correlating with the degree of macrophage infiltration. In vitro infection of human primary macrophages highlights that SARS-CoV-2 entry is increased in cholesterol-loaded macrophages (foam cells) and is dependent, in part, on neuropilin-1 (NRP-1). Furthermore, although viral replication is abortive, SARS-CoV-2 induces a robust inflammatory response that includes interleukins IL-6 and IL-1{beta}, key cytokines known to trigger ischemic cardiovascular events. SARS-CoV-2 infection of human atherosclerotic vascular explants recapitulates the immune response seen in cultured macrophages, including pro-atherogenic cytokine secretion. Collectively, our data establish that SARS-CoV-2 infects macrophages in coronary atherosclerotic lesions, resulting in plaque inflammation that may promote acute CV complications and long-term risk for CV events.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.08.30.555188">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.08.30.555188" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.08.30.555188">
        <p class="paperTitle">Immune Evasion and Membrane Fusion of SARS-CoV-2 XBB Subvariants EG.5.1 and XBB.2.3</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.08.30.555188" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.08.30.555188" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Faraone, J. N.; Qu, P.; Goodarzi, N.; Zheng, Y.-M.; Carlin, C.; Saif, L. J.; Oltz, E. M.; Xu, K.; Jones, D.; Gumina, R. J.; Liu, S.-L.</p>
        <p class="info">Score: 76.4, Published: 2023-08-30 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.08.30.555188' target='https://doi.org/10.1101/2023.08.30.555188'> 10.1101/2023.08.30.555188</a></p>
        <p class="abstract">Immune evasion by SARS-CoV-2 paired with immune imprinting from monovalent mRNA vaccines has resulted in attenuated neutralizing antibody responses against Omicron subvariants. In this study, we characterized two new XBB variants rising in circulation -- EG.5.1 and XBB.2.3, for their ability of neutralization and syncytia formation. We determined the neutralizing antibody in sera of individuals that received a bivalent mRNA vaccine booster, BA.4/5-wave infection, or XBB.1.5-wave infection. Bivalent vaccination-induced antibodies neutralized efficiently ancestral D614G, but to a much less extent, two new EG.5.1 and XBB.2.3 variants. In fact, the enhanced neutralization escape of EG.5.1 appeared to be driven by its key defining mutation XBB.1.5-F456L. Notably, infection by BA.4/5 or XBB.1.5 afforded little, if any, neutralization against EG.5.1, XBB.2.3 and previous XBB variants -- especially in unvaccinated individuals, with average neutralizing antibody titers near the limit of detection. Additionally, we investigated the infectivity, fusion activity, and processing of variant spikes for EG.5.1 and XBB.2.3 in HEK293T-ACE2 and CaLu-3 cells but found no significant differences compared to earlier XBB variants. Overall, our findings highlight the continued immune evasion of new Omicron subvariants and, more importantly, the need to reformulate mRNA vaccines to include XBB spikes for better protection.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.08.30.555211">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.08.30.555211" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.08.30.555211">
        <p class="paperTitle">Convergent evolution of SARS-CoV-2 XBB lineages on receptor-binding domain 455-456 enhances antibody evasion and ACE2 binding</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.08.30.555211" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.08.30.555211" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Jian, F.; Yang, S.; Yu, Y.; Song, W.; Yisimayi, A.; Chen, X.; Xu, Y.; Wang, P.; Yu, L.; Wang, J.; Liu, L.; Niu, X.; Wang, J.; Xiao, T.; Gu, Q.; Shao, F.; Jin, R.; Shen, Z.; Wang, Y.; Cao, Y. R.</p>
        <p class="info">Score: 53.9, Published: 2023-08-31 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.08.30.555211' target='https://doi.org/10.1101/2023.08.30.555211'> 10.1101/2023.08.30.555211</a></p>
        <p class="abstract">Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) XBB lineages have achieved dominance worldwide and keep on evolving. Convergent evolution of XBB lineages on the receptor-binding domain (RBD) L455F and F456L is observed, resulting in variants like EG.5, FL.1.5.1, XBB.1.5.70, and HK.3. Here, we show that neutralizing antibody (NAb) evasion drives the convergent evolution of F456L, while the epistatic shift caused by F456L enables the subsequent convergence of L455F through ACE2 binding enhancement and further immune evasion. Specifically, L455F and F456L evades Class 1 NAbs, which could reduce the neutralization efficacy of XBB breakthrough infection (BTI) and reinfection convalescent plasma. Importantly, L455F single substitution significantly dampens receptor binding; however, the combination of L455F and F456L forms an adjacent residue flipping, which leads to enhanced NAbs resistance and ACE2 binding affinity. Our results indicate the evolution flexibility contributed by epistasis cannot be underestimated, and the evolution potential of SARS-CoV-2 RBD remains high.

HighlightsO_LIL455F and F456L enhance the resistance to Class 1 NAbs
C_LIO_LIL455F and F456L lower neutralization of XBB BTI convalescent plasma
C_LIO_LIL455F&#43;F456L flipping significantly increases ACE2 binding affinity
C_LI</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.08.30.555580">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.08.30.555580" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.08.30.555580">
        <p class="paperTitle">Altered DNA methylation underlies monocyte dysregulation and innate exhaustion memory in sepsis</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.08.30.555580" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.08.30.555580" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Caldwell, B. A.; Wu, Y.; Wang, J.; Li, L.</p>
        <p class="info">Score: 48.6, Published: 2023-08-31 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.08.30.555580' target='https://doi.org/10.1101/2023.08.30.555580'> 10.1101/2023.08.30.555580</a></p>
        <p class="abstract">Innate immune memory is the process by which pathogen exposure elicits cell-intrinsic states to alter the strength of future immune challenges. Such altered memory states drive monocyte dysregulation during sepsis, promoting pathogenic behavior characterized by pro-inflammatory, immunosuppressive gene expression in concert with emergency hematopoiesis. Epigenetic changes, notably in the form of histone modifications, have been shown to underlie innate immune memory, but the contribution of DNA methylation to this process remains poorly understood. Using an ex vivo sepsis model, we discovered broad changes in DNA methylation throughout the genome of exhausted monocytes, including at several genes previously implicated as major drivers of immune dysregulation during sepsis and Covid-19 infection (e.g. Plac8). Methylome alterations are driven in part by Wnt signaling inhibition in exhausted monocytes, and can be reversed through treatment with DNA methyltransferase inhibitors, Wnt agonists, or immune training molecules. Importantly, these changes are recapitulated in septic mice following cecal slurry injection, resulting in stable changes at critical immune genes that support the involvement of DNA methylation in acute and long-term monocyte dysregulation during sepsis.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.09.01.555815">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.09.01.555815" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.09.01.555815">
        <p class="paperTitle">Antigenicity and infectivity characterization of SARS-CoV-2 BA.2.86</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.09.01.555815" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.09.01.555815" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Yang, S.; Yu, Y.; Jian, F.; Song, W.; Yisimayi, A.; Chen, X.; Xu, Y.; Wang, P.; Yu, L.; Wang, J.; Niu, X.; Wang, J.; Xiao, T.; An, R.; Wang, Y.; Gu, Q.; Shao, F.; Jin, R.; Shen, Z.; Wang, Y.; Cao, Y. R.</p>
        <p class="info">Score: 33.8, Published: 2023-09-04 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.09.01.555815' target='https://doi.org/10.1101/2023.09.01.555815'> 10.1101/2023.09.01.555815</a></p>
        <p class="abstract">The recently identified SARS-CoV-2 variant, BA.2.86, which carries a substantial number of Spike mutations, has raised a global alarm. An immediate assessment of its antigenic properties and infectivity is necessary. Here, we reveal the distinct antigenicity of BA.2.86 compared with previous variants including XBB.1.5. BA.2.86 significantly evades convalescent plasma from XBB breakthrough infection (BTI) and reinfections. Key mutations that mediate the enhanced resistance include N450D, K356T, L452W, A484K, V483del, and V445H on the RBD, while BA.2.86&#39;s NTD mutations and E554K on SD1 also largely contribute. However, we found that BA.2.86 pseudovirus exhibits compromised efficiency of infecting HEK293T-hACE2 cells compared to XBB.1.5 and EG.5, which may be caused by K356T, V483del, and E554K, and could potentially limit BA.2.86&#39;s transmissibility. In sum, it appears that BA.2.86 has traded its infectivity for higher immune evasion during long-term host-viral evolution. Close attention should be paid to monitoring additional mutations that could improve BA.2.86&#39;s infectivity.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.08.31.555785">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.08.31.555785" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.08.31.555785">
        <p class="paperTitle">Tick hemocytes have pleiotropic roles in microbial infection and arthropod fitness</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.08.31.555785" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.08.31.555785" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Rolandelli, A.; Laukaitis-Yousey, H.; Bogale, H.; Singh, N.; Samaddar, S.; ONeal, A.; Ferraz, C.; Butnaru, M.; Mameli, E.; Xia, B.; Mendes, M. T.; Butler, L. R.; Marnin, L.; Cabrera Paz, F.; Valencia, L.; Rana, V.; Skerry, C.; Pal, U.; Mohr, S.; Perrimon, N.; Serre, D.; Pedra, J.</p>
        <p class="info">Score: 15.9, Published: 2023-09-03 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.08.31.555785' target='https://doi.org/10.1101/2023.08.31.555785'> 10.1101/2023.08.31.555785</a></p>
        <p class="abstract">Uncovering the complexity of systems in non-model organisms is critical for understanding arthropod immunology. Prior efforts have mostly focused on Dipteran insects, which only account for a subset of existing arthropod species in nature. Here, we describe immune cells or hemocytes from the clinically relevant tick Ixodes scapularis using bulk and single cell RNA sequencing combined with depletion via clodronate liposomes, RNA interference, Clustered Regularly Interspaced Short Palindromic Repeats activation (CRISPRa) and RNA-fluorescence in situ hybridization (FISH). We observe molecular alterations in hemocytes upon tick infestation of mammals and infection with either the Lyme disease spirochete Borrelia burgdorferi or the rickettsial agent Anaplasma phagocytophilum. We predict distinct hemocyte lineages and reveal clusters exhibiting defined signatures for immunity, metabolism, and proliferation during hematophagy. Furthermore, we perform a mechanistic characterization of two I. scapularis hemocyte markers: hemocytin and astakine. Depletion of phagocytic hemocytes affects hemocytin and astakine levels, which impacts blood feeding and molting behavior of ticks. Hemocytin specifically affects the c-Jun N-terminal kinase (JNK) signaling pathway, whereas astakine alters hemocyte proliferation in I. scapularis. Altogether, we uncover the heterogeneity and pleiotropic roles of hemocytes in ticks and provide a valuable resource for comparative biology in arthropods.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.08.29.555265">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.08.29.555265" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.08.29.555265">
        <p class="paperTitle">Unanticipated interacting features of human gut-associated lymphoid tissues link microbiota, intestinal immunity and autoimmunity</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.08.29.555265" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.08.29.555265" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Montorsi, L.; Pitcher, M. J.; Zhao, Y.; Demonti, A.; Tull, T. J.; Dionisi, C.; Dhami, P.; Ellis, R. J.; Bishop, C.; Sanderson, J.; Jain, S.; D&#39;Cruz, D.; Gibbons, D.; Winkler, T. H.; Bemark, M.; Ciccarelli, F. D.; Spencer, J.</p>
        <p class="info">Score: 14.7, Published: 2023-08-31 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.08.29.555265' target='https://doi.org/10.1101/2023.08.29.555265'> 10.1101/2023.08.29.555265</a></p>
        <p class="abstract">Gut-associated lymphoid tissue (GALT) is organised lymphoid tissue that is chronically activated by the intestinal microbiota. It generates the IgA response that is critical for intestinal homeostasis. By iterative application of multiplexed technologies, we identify enrichment of double-negative 2 (DN2:CD27-IgD-CD21loCD11chi) B cells in GALT, where they comprise the majority of intraepithelial and subepithelial B cells. We show that DN2 B cells in GALT interact with DC in the sub-epithelial dome that express DNASE1L3 and microbicides. Unlike in mice, DNASE1L3 in humans does not associate with apoptotic debris, but is located between sampled bacteria and host tissue where it is co-expressed with C1Q, consistent with management of bacterial debris. Thus we demonstrate that DN2 B cells that are otherwise associated with lupus nephritis, and DNASE1L3 and C1q that are lupus autoantigens, are microbiota-associated, interacting components of normal intestinal immunity.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.08.31.555710">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.08.31.555710" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.08.31.555710">
        <p class="paperTitle">Dysregulation of γδ intraepithelial lymphocytes precedes Crohn&#39;s disease-like ileitis</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.08.31.555710" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.08.31.555710" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Xu, W.; Golovchenko, N. B.; Fong, A.; Achi, S.; Bucar, E. B.; Vidmar, K. J.; Zhang, L.; Frey, M. R.; Prinz, I.; Pizarro, T. T.; Kollias, G.; Edelblum, K. L.</p>
        <p class="info">Score: 14.4, Published: 2023-09-03 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.08.31.555710' target='https://doi.org/10.1101/2023.08.31.555710'> 10.1101/2023.08.31.555710</a></p>
        <p class="abstract">Intraepithelial lymphocytes expressing the {gamma}{delta} T cell receptor ({gamma}{delta} IELs) provide immunosurveillance of the intestinal barrier. Interestingly, {gamma}{delta} IEL number is reduced in patients with active Crohn&#39;s disease (CD). Here, we report an underappreciated role for {gamma}{delta} IELs in maintaining mucosal tolerance during the onset and progression of CD-like ileitis using the TNF{Delta}ARE/&#43; mouse model. Decreased epithelial HNF4G/BTNL expression is followed by a loss of ileal {gamma}{delta} IELs and impaired barrier surveillance prior to the histological onset of disease. A reduction of immunoregulatory CD39&#43; {gamma}{delta} IELs coincides with the influx of immature, peripheral CD39- {gamma}{delta} T cells into the epithelium leading to an expansion of induced IELs, while an earlier depletion of {gamma}{delta} IELs correlates with accelerated onset of ileal inflammation. Our findings identify multiple layers of {gamma}{delta} IEL dysregulation prior to ileitis development indicating that the loss of tissue-resident immunoregulatory {gamma}{delta} IELs may contribute to the initiation of ileal CD.</p>
      </div>
    </div>
  </div>
</div>









<script src="/js/bundle.min.js" defer></script>



  </div>

  <footer class="post-footer">
    <ul class="post-tags">
    </ul>
  </footer>
</article>
    </main>
    
<footer class="footer">
    <span>&copy; 2023 <a href="https://trxiv.yorks0n.com">TRxiv2</a></span>
    <span>
        · Made by Yorkson
    </span>
</footer>
<a href="#top" aria-label="go to top" title="Go to Top (Alt + G)" class="top-link" id="top-link" accesskey="g">
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 12 6" fill="currentColor">
        <path d="M12 6H0l6-6z" />
    </svg>
</a>

<script>
    let menu = document.getElementById('menu')
    if (menu) {
        menu.scrollLeft = localStorage.getItem("menu-scroll-position");
        menu.onscroll = function () {
            localStorage.setItem("menu-scroll-position", menu.scrollLeft);
        }
    }

    document.querySelectorAll('a[href^="#"]').forEach(anchor => {
        anchor.addEventListener("click", function (e) {
            e.preventDefault();
            var id = this.getAttribute("href").substr(1);
            if (!window.matchMedia('(prefers-reduced-motion: reduce)').matches) {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView({
                    behavior: "smooth"
                });
            } else {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView();
            }
            if (id === "top") {
                history.replaceState(null, null, " ");
            } else {
                history.pushState(null, null, `#${id}`);
            }
        });
    });

</script>
<script>
    var mybutton = document.getElementById("top-link");
    window.onscroll = function () {
        if (document.body.scrollTop > 800 || document.documentElement.scrollTop > 800) {
            mybutton.style.visibility = "visible";
            mybutton.style.opacity = "1";
        } else {
            mybutton.style.visibility = "hidden";
            mybutton.style.opacity = "0";
        }
    };

</script>
<script>
    document.getElementById("theme-toggle").addEventListener("click", () => {
        if (document.body.className.includes("dark")) {
            document.body.classList.remove('dark');
            localStorage.setItem("pref-theme", 'light');
        } else {
            document.body.classList.add('dark');
            localStorage.setItem("pref-theme", 'dark');
        }
    })

</script>
</body>

</html>
